Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific NXPH1 ENSG00000122584 Neurexophilin 1 7 8433955-8752963 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA020062 Uncertain Group enriched 83 adrenal gland: 52.3;cerebral cortex: 47.3 breast: 0.5 UNC5A KIAA1976, UNC5H1 ENSG00000113763 Unc-5 netrin receptor A 5 176810477-176880895 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071450 Approved Plasma membrane
Cytosol Group enriched 22 adrenal gland: 10.4;cerebral cortex: 35.5 lymph node: 1.0 DLK1 Delta1, FA1, pG2, Pref-1, ZOG ENSG00000185559 Delta-like 1 homolog (Drosophila) 14 100725705-100738224 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005872, HPA053879, HPA062262 Supported Approved Golgi apparatus Group enriched 20 adrenal gland: 1598.8;placenta: 2319.0 ovary: 99.9 LRRC38 ENSG00000162494 Leucine rich repeat containing 38 1 13474977-13514048 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA038778 Approved Group enriched 19 adrenal gland: 20.0;skeletal muscle: 10.5 placenta: 0.8 FNDC9 C5orf40, MGC27121 ENSG00000172568 Fibronectin type III domain containing 9 5 157341600-157345721 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA011115, HPA017291 Approved Group enriched 17 adrenal gland: 6.3;cerebral cortex: 20.7 appendix: 0.7 FAM19A3 TAFA-3 ENSG00000184599 Family with sequence similarity 19 (chemokine (C-C motif)-like), member A3 1 112720419-112727235 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055927 Approved Group enriched 16 adrenal gland: 20.0;testis: 8.7 epididymis: 0.9 NPY PYY4 ENSG00000122585 Neuropeptide Y 7 24284163-24291865 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009978, CAB016733, CAB034368, HPA044572, HPA056798 Supported Supported Validated Golgi apparatus Group enriched 16 adrenal gland: 154.2;cerebral cortex: 212.3;prostate: 448.9 appendix: 16.6 RAB3C ENSG00000152932 RAB3C, member RAS oncogene family 5 58582221-58859394 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA003160, HPA048156 Supported Approved Cytosol Group enriched 16 adrenal gland: 12.1;cerebral cortex: 55.5 small intestine: 2.0 CALY CALCYON, DRD1IP, NSG3 ENSG00000130643 Calcyon neuron-specific vesicular protein 10 133324072-133336935 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042283 Uncertain Group enriched 13 adrenal gland: 23.6;cerebral cortex: 77.3 testis: 3.8 FAM166B ENSG00000215187 Family with sequence similarity 166, member B 9 35561831-35563899 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045540 Uncertain Group enriched 13 adrenal gland: 371.3;fallopian tube: 157.1;skeletal muscle: 82.6 epididymis: 15.9 GPR22 ENSG00000172209 G protein-coupled receptor 22 7 107470018-107475659 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 13 adrenal gland: 2.4;cerebral cortex: 9.5;cervix, uterine: 6.3;endometrium: 5.0;heart muscle: 11.9 smooth muscle: 0.5 GSTA3 ENSG00000174156 Glutathione S-transferase alpha 3 6 52847910-52909685 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004342, HPA048934, HPA053817 Approved Supported Cytosol Group enriched 11 adrenal gland: 56.5;fallopian tube: 100.6;placenta: 31.8;skin: 30.6;testis: 20.2 parathyroid gland: 4.2 ASB4 ASB-4 ENSG00000005981 Ankyrin repeat and SOCS box containing 4 7 95478444-95540232 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055240 Uncertain Group enriched 10 adrenal gland: 50.4;skeletal muscle: 11.5 placenta: 2.9 FSTL5 DKFZp566D234, KIAA1263 ENSG00000168843 Follistatin-like 5 4 161383897-162164035 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045909, HPA046724 Uncertain Group enriched 10 adrenal gland: 7.8;cerebral cortex: 16.3 testis: 1.1 MCF2 ARHGEF21, DBL ENSG00000101977 MCF.2 cell line derived transforming sequence X 139581770-139708227 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 10 adrenal gland: 38.5;cerebral cortex: 8.7;epididymis: 14.7;ovary: 12.8;seminal vesicle: 23.7;testis: 34.4 prostate: 2.1 RTL1 Mar1, MART1, PEG11 ENSG00000254656 Retrotransposon-like 1 14 100880655-100884847 Predicted membrane proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA066979 Approved Cytosol Group enriched 10 adrenal gland: 2.4;placenta: 4.8 cerebral cortex: 0.3 SRRM3 FLJ37078 ENSG00000177679 Serine/arginine repetitive matrix 3 7 76201900-76287288 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA019337 Uncertain Approved Plasma membrane
Intermediate filaments
Microtubules Group enriched 10 adrenal gland: 2.7;cerebral cortex: 8.5;testis: 1.8 stomach: 0.4 BRINP2 DBCCR1L2, FAM5B ENSG00000198797 Bone morphogenetic protein/retinoic acid inducible neural-specific 2 1 177171497-177282422 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA050681, HPA061920 Uncertain Approved Nucleoli
Vesicles Group enriched 9 adrenal gland: 11.5;cerebral cortex: 35.5 testis: 2.4 TMEM130 DKFZp761L1417, FLJ42643 ENSG00000166448 Transmembrane protein 130 7 98846488-98870771 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA012928 Uncertain Supported Golgi apparatus Group enriched 9 adrenal gland: 49.3;cerebral cortex: 183.7;testis: 70.8 epididymis: 11.5 ZFR2 KIAA1086 ENSG00000105278 Zinc finger RNA binding protein 2 19 3804024-3869032 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043275, HPA055678 Uncertain Uncertain Nucleoplasm Group enriched 9 adrenal gland: 3.8;cerebral cortex: 12.7;testis: 19.0 fallopian tube: 1.3 ATP2B3 CFAP39, CLA2, PMCA3, SCAX1 ENSG00000067842 ATPase, Ca++ transporting, plasma membrane 3 X 153517676-153582939 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001583 Supported Uncertain Golgi apparatus
Plasma membrane Group enriched 8 adrenal gland: 12.2;cerebral cortex: 19.1 fallopian tube: 2.0 CACNA1B CACNL1A5, CACNN, Cav2.2 ENSG00000148408 Calcium channel, voltage-dependent, N type, alpha 1B subunit 9 137877789-138124624 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044347 Uncertain Group enriched 8 adrenal gland: 3.7;cerebral cortex: 14.9;fallopian tube: 4.8;testis: 7.6 prostate: 1.0 ELAVL4 HUD, PNEM ENSG00000162374 ELAV like neuron-specific RNA binding protein 4 1 50048014-50203786 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004442 Supported Group enriched 8 adrenal gland: 10.8;cerebral cortex: 53.5;testis: 10.8 appendix: 2.9 KCNMB4 ENSG00000135643 Potassium channel subfamily M regulatory beta subunit 4 12 70366276-70434292 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA072287 Approved Cytosol Group enriched 8 adrenal gland: 19.6;cerebral cortex: 38.2 placenta: 3.7 MCF2L2 ARHGEF22, KIAA0861 ENSG00000053524 MCF.2 cell line derived transforming sequence-like 2 3 183178043-183428778 Disease related genes, Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA038946, HPA038947 Uncertain Approved Plasma membrane
Cytosol Group enriched 8 adrenal gland: 10.3;cerebral cortex: 17.1;parathyroid gland: 7.4;spleen: 3.5;testis: 4.6 prostate: 1.0 MRAP B27, C21orf61, FALP ENSG00000170262 Melanocortin 2 receptor accessory protein 21 32291813-32314784 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA011024 Uncertain Group enriched 8 adipose tissue: 51.9;adrenal gland: 65.6 breast: 6.9 PENK ENSG00000181195 Proenkephalin 8 56436674-56446734 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013138, CAB016390 Supported Group enriched 8 adrenal gland: 568.1;testis: 207.8 prostate: 47.7 PROKR1 GPR73, GPR73a, PKR1, ZAQ ENSG00000169618 Prokineticin receptor 1 2 68643589-68658247 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA029396 Uncertain Group enriched 8 adipose tissue: 1.7;adrenal gland: 1.4;epididymis: 4.3 testis: 0.3 REEP6 C19orf32, DP1L1, FLJ25383 ENSG00000115255 Receptor accessory protein 6 19 1490747-1497927 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003895, HPA048015 Approved Supported Endoplasmic reticulum Group enriched 8 adrenal gland: 48.4;duodenum: 170.8;liver: 76.3;small intestine: 170.5;testis: 181.6 prostate: 17.0 RGS7 ENSG00000182901 Regulator of G-protein signaling 7 1 240775514-241357230 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000688, CAB017561 Supported Approved Nucleus Group enriched 8 adrenal gland: 10.8;cerebral cortex: 47.0;testis: 13.4 stomach: 2.9 TMEM179 C14orf90, FLJ42486, TMEM179A ENSG00000258986 Transmembrane protein 179 14 104474678-104605647 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA002942 Uncertain Mitochondria Group enriched 8 adrenal gland: 14.7;cerebral cortex: 28.0 testis: 2.5 ARC Arg3.1, KIAA0278 ENSG00000198576 Activity-regulated cytoskeleton-associated protein 8 142611044-142614472 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056430 Approved Vesicles
Microtubules Group enriched 7 adipose tissue: 14.1;adrenal gland: 13.4;cerebral cortex: 14.4;gallbladder: 3.3;seminal vesicle: 5.5 placenta: 1.4 CADPS CAPS, CAPS1, KIAA1121 ENSG00000163618 Ca++-dependent secretion activator 3 62398346-62875389 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059328 Supported Approved Vesicles Group enriched 7 adrenal gland: 21.7;cerebral cortex: 94.3 heart muscle: 8.4 DNER bet, UNQ26 ENSG00000187957 Delta/notch-like EGF repeat containing 2 229357629-229714558 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017320 Approved Group enriched 7 adrenal gland: 74.9;cerebral cortex: 176.5 salivary gland: 17.4 DPP10 DPRP3 ENSG00000175497 Dipeptidyl-peptidase 10 (non-functional) 2 114442299-115845752 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048767 Uncertain Approved Nucleus
Vesicles
Cytosol Group enriched 7 adrenal gland: 14.2;cerebral cortex: 34.8 pancreas: 3.6 FAM135B C8ORFK32 ENSG00000147724 Family with sequence similarity 135, member B 8 138130023-138496822 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA023911, HPA023950, HPA024815 Uncertain Approved Nucleoplasm
Nuclear membrane Group enriched 7 adrenal gland: 3.6;cerebral cortex: 8.3;testis: 7.2 colon: 0.8 GCGR GGR ENSG00000215644 Glucagon receptor 17 81804132-81814013 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071228 Approved Golgi apparatus Group enriched 7 adrenal gland: 6.6;kidney: 8.5;liver: 20.9;parathyroid gland: 9.4 skin: 1.6 IGLON5 LOC402665 ENSG00000142549 IgLON family member 5 19 51311848-51330354 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041994 Approved Uncertain Nucleus Group enriched 7 adrenal gland: 2.3;cerebral cortex: 11.1;testis: 9.5 seminal vesicle: 1.1 KCNK9 K2p9.1, TASK-3, TASK3 ENSG00000169427 Potassium channel, two pore domain subfamily K, member 9 8 139600838-139703056 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 7 adrenal gland: 4.8;cerebral cortex: 4.8 cervix: 0.7 MYT1 MTF1, MYTI, NZF2, PLPB1, ZC2HC4A ENSG00000196132 Myelin transcription factor 1 20 64151791-64242253 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006303 Uncertain Supported Nucleoplasm
Cytosol Group enriched 7 adrenal gland: 2.5;cerebral cortex: 5.7 testis: 0.6 NR0B1 AHC, AHCH, DAX1, DSS, NR0B1 ENSG00000169297 Nuclear receptor subfamily 0, group B, member 1 X 30304206-30309598 Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA070839 Supported Nucleoplasm Group enriched 7 adrenal gland: 27.9;testis: 34.9 ovary: 4.2 PRLHR GPR10, PrRPR ENSG00000119973 Prolactin releasing hormone receptor 10 118589989-118595699 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA039361 Supported Group enriched 7 adrenal gland: 6.5;cerebral cortex: 3.5;endometrium: 3.9;smooth muscle: 5.4 seminal vesicle: 0.7 SCARB1 CD36L1, CLA-1, CLA1, SR-BI, SRB1 ENSG00000073060 Scavenger receptor class B, member 1 12 124776856-124882668 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA066285, CAB070124 Supported Approved Vesicles Group enriched 7 adrenal gland: 762.1;placenta: 284.3 liver: 71.6 SCG2 CHGC, SgII, SN ENSG00000171951 Secretogranin II 2 223596940-223602503 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002519, HPA011893 Approved Supported Group enriched 7 adrenal gland: 449.0;cerebral cortex: 232.7 duodenum: 46.3 ADGRV1 DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1 ENSG00000164199 Adhesion G protein-coupled receptor V1 5 90529344-91164221 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067503 Approved Group enriched 6 adrenal gland: 56.5;cerebral cortex: 29.1 thyroid gland: 6.6 ANO4 FLJ34221, FLJ34272, FLJ35277, TMEM16D ENSG00000151572 Anoctamin 4 12 100717526-101128641 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA053412 Uncertain Group enriched 6 adrenal gland: 17.6;cerebral cortex: 10.0;cervix, uterine: 12.5;endometrium: 8.3;ovary: 10.9;prostate: 10.9;seminal vesicle: 11.3 testis: 2.0 ARSF ENSG00000062096 Arylsulfatase F X 3041471-3112726 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA000549 Uncertain Cytosol Group enriched 6 adrenal gland: 4.0;cerebral cortex: 2.1;epididymis: 2.1;esophagus: 2.3;kidney: 8.0;skin: 6.7 urinary bladder: 0.6 AS3MT CYT19 ENSG00000214435 Arsenite methyltransferase 10 102869516-102901899 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017856, HPA027708 Approved Group enriched 6 adrenal gland: 252.7;parathyroid gland: 117.7 liver: 30.5 ASTN1 ASTN ENSG00000152092 Astrotactin 1 1 176857302-177164973 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA074112 Approved Golgi apparatus
Vesicles Group enriched 6 adrenal gland: 19.7;cerebral cortex: 67.0 ovary: 7.4 CDH22 C20orf25, dJ998H6.1 ENSG00000149654 Cadherin 22, type 2 20 46173733-46308498 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA012164 Uncertain Group enriched 6 adrenal gland: 2.0;cerebral cortex: 10.3;fallopian tube: 2.3;skin: 5.2 testis: 0.8 CELF3 BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4 ENSG00000159409 CUGBP, Elav-like family member 3 1 151702404-151716814 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006292 Uncertain Approved Nucleoplasm Group enriched 6 adrenal gland: 15.3;cerebral cortex: 51.8 stomach: 5.6 CELSR3 ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2 ENSG00000008300 Cadherin, EGF LAG seven-pass G-type receptor 3 3 48636469-48662915 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062866 Approved Group enriched 6 adrenal gland: 1.6;cerebral cortex: 6.0;testis: 3.6 parathyroid gland: 0.6 FRMD5 MGC14161 ENSG00000171877 FERM domain containing 5 15 43870761-44195252 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011746, HPA013961 Uncertain Uncertain Golgi apparatus
Centrosome Group enriched 6 adrenal gland: 7.1;cerebral cortex: 20.1;heart muscle: 7.1;testis: 5.5 fallopian tube: 1.6 GALNT13 GalNAc-T13, KIAA1918 ENSG00000144278 Polypeptide N-acetylgalactosaminyltransferase 13 2 153871913-154453849 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA060775 Approved Group enriched 6 adrenal gland: 6.6;cerebral cortex: 32.8 lung: 3.2 GJD2 CX36, GJA9 ENSG00000159248 Gap junction protein, delta 2, 36kDa 15 34751032-34754965 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014355 Uncertain Group enriched 6 adrenal gland: 8.0;cerebral cortex: 1.9 pancreas: 0.8 LUZP2 ENSG00000187398 Leucine zipper protein 2 11 24496970-25082631 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039007, HPA046161 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Group enriched 6 adrenal gland: 8.5;cerebral cortex: 33.1 prostate: 3.3 NR5A1 AD4BP, ELP, FTZ1, FTZF1, SF-1 ENSG00000136931 Nuclear receptor subfamily 5, group A, member 1 9 124481236-124507430 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 adrenal gland: 138.2;ovary: 36.3;spleen: 154.3 testis: 19.6 RTBDN FLJ36353 ENSG00000132026 Retbindin 19 12825478-12835428 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA052511 Approved Endoplasmic reticulum Group enriched 6 adrenal gland: 4.6;cerebral cortex: 14.7;testis: 3.5 stomach: 1.2 TCEAL6 WEX2 ENSG00000204071 Transcription elongation factor A (SII)-like 6 X 102140476-102142970 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045564, HPA058982 Uncertain Group enriched 6 adrenal gland: 15.0;cerebral cortex: 65.3;testis: 35.6 endometrium: 6.2 VAT1L KIAA1576 ENSG00000171724 Vesicle amine transport 1-like 16 77788530-77980107 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044061, CAB046032 Approved Approved Cytosol Group enriched 6 adrenal gland: 91.0;cerebral cortex: 38.9 heart muscle: 10.6 ZIM2 ZNF656 ENSG00000269699 Zinc finger, imprinted 2 19 56774552-56840729 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA071856 Approved Nuclear speckles
Cytosol Group enriched 6 adrenal gland: 5.8;cerebral cortex: 5.1;ovary: 10.0;placenta: 6.8;testis: 7.8 endometrium: 1.1 AADAC CES5A1, DAC ENSG00000114771 Arylacetamide deacetylase 3 151814037-151828488 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002911 Approved Group enriched 5 adrenal gland: 151.1;duodenum: 187.8;liver: 385.8;small intestine: 220.5 stomach: 43.9 ACRC ENSG00000147174 Acidic repeat containing X 71578411-71613583 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA023476 Supported Approved Vesicles Group enriched 5 adrenal gland: 5.9;testis: 20.6 spleen: 2.5 AOX1 AO, AOH1 ENSG00000138356 Aldehyde oxidase 1 2 200585868-200677064 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040199, HPA040215 Approved Supported Nuclear bodies
Cytosol Group enriched 5 adrenal gland: 370.6;kidney: 96.7;liver: 432.0 ovary: 56.6 CALN1 ENSG00000183166 Calneuron 1 7 71779491-72447151 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036278, HPA036708 Approved Uncertain Vesicles
Plasma membrane Group enriched 5 adrenal gland: 14.8;cerebral cortex: 46.5 testis: 6.0 CDH12 Br-cadherin, CDHB ENSG00000154162 Cadherin 12, type 2 (N-cadherin 2) 5 21750673-22853622 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA029325 Uncertain Approved Vesicles Group enriched 5 adrenal gland: 2.5;cerebral cortex: 3.8;cervix, uterine: 5.3;fallopian tube: 4.0;skin: 1.1;testis: 2.7 breast: 0.6 GPR83 GPR72 ENSG00000123901 G protein-coupled receptor 83 11 94377311-94401419 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 5 adrenal gland: 1.0;cerebral cortex: 4.6;thyroid gland: 5.2 epididymis: 0.6 LHCGR HHG, LCGR, LGR2, LHR, ULG5 ENSG00000138039 Luteinizing hormone/choriogonadotropin receptor 2 48686775-48755730 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009814 Uncertain Group enriched 5 adipose tissue: 1.3;adrenal gland: 1.1;ovary: 1.5;testis: 4.3;thyroid gland: 1.1 breast: 0.3 NGB ENSG00000165553 Neuroglobin 14 77265483-77271312 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042615, HPA058596 Supported Group enriched 5 adrenal gland: 10.2;cerebral cortex: 4.8;fallopian tube: 2.1 pancreas: 1.0 PABPC1L2A RBM32A ENSG00000186288 Poly(A) binding protein, cytoplasmic 1-like 2A X 73077276-73079512 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041573 Approved Group enriched 5 adrenal gland: 2.0;cerebral cortex: 6.7;prostate: 3.7;testis: 2.8 epididymis: 0.7 PEG10 HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3 ENSG00000242265 Paternally expressed 10 7 94656325-94669695 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021324, HPA029915, HPA051038 Supported Validated Nucleus
Cytosol Group enriched 5 adrenal gland: 225.1;placenta: 659.4 ovary: 80.5 PNMAL2 KIAA1183 ENSG00000204851 Paraneoplastic Ma antigen family-like 2 19 46486906-46496498 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA054810 Approved Group enriched 5 adrenal gland: 12.2;cerebral cortex: 33.0 ovary: 4.3 PPM1E CaMKP-N, KIAA1072, POPX1, PP2CH ENSG00000175175 Protein phosphatase, Mg2+/Mn2+ dependent, 1E 17 58755869-58985176 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018462, HPA019263 Approved Supported Nucleus
Nucleoli Group enriched 5 adrenal gland: 7.3;cerebral cortex: 20.5;testis: 12.1 fallopian tube: 2.4 PPP1R17 C7orf16, GSBS ENSG00000106341 Protein phosphatase 1, regulatory subunit 17 7 31686715-31708455 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047819 Supported Group enriched 5 adrenal gland: 4.9;cerebral cortex: 2.6;testis: 1.1 lung: 0.5 SEPT4 ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2 ENSG00000108387 Septin 4 17 58520250-58540818 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006855, HPA021587, HPA022905 Supported Supported Nucleoplasm Group enriched 5 adrenal gland: 218.2;cerebral cortex: 288.7;spleen: 57.8 adipose tissue: 36.8 SHISA4 C1orf40, hShisa4, TMEM58 ENSG00000198892 Shisa family member 4 1 201888680-201892306 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA061273 Uncertain Group enriched 5 adrenal gland: 23.6;cerebral cortex: 45.5;skeletal muscle: 94.5 heart muscle: 10.8